Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lexaria Bioscience Corp LEXX

Alternate Symbol(s):  LEXXW

Healthcare
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the... see more

Recent & Breaking News (NDAQ:LEXX)

Lexaria Bioscience Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $9.6 Million Upsized Public Offering

TheNewsWire January 12, 2021

Lexaria Announces Effective Date for Reverse Stock Split

TheNewsWire January 8, 2021

Lexaria Expands COVID-19 Drug Research Program Utilizing Proprietary DehydraTECH

TheNewsWire December 22, 2020

Lexaria Closes Sale of Non-Pharmaceutical THC-Related Assets

TheNewsWire December 10, 2020

Lexaria Bioscience Corp. Discusses Demonstration of Improved Oral Delivery for Antiviral Drugs with The Stock Day Podcast

Newsfile December 8, 2020

Lexaria to Highlight its DehydraTECHTM Technology at Four Upcoming Investor Conferences

Accesswire December 7, 2020

Lexaria to Highlight its DehydraTECH(TM) Technology at Four Upcoming Investor Conferences

TheNewsWire December 7, 2020

Lexaria's Patented Technology Significantly Enhances Oral Delivery of Antiviral Drugs

TheNewsWire December 1, 2020

Lexaria Sells Non-Pharmaceutical THC-Related Assets for $3.85 Million

Stockhouse Editorial November 19, 2020

Lexaria Bioscience Sells Non-Pharmaceutical THC-Related Assets for CDN$3.85M

TheNewsWire November 19, 2020

Lexaria Bioscience Corp. Discusses the Significance of Their Intellectual Property with The Stock Day Podcast

Newsfile November 17, 2020

Lexaria Bioscience Advances 2021 Strategic Initiatives

TheNewsWire November 5, 2020

Lexaria Bioscience Extends Warrant Term

Accesswire October 26, 2020

Lexaria Proprietary DehydraTECH-Enabled CBD Powders Business Growing Faster than Expected

TheNewsWire October 22, 2020

Lexaria Bioscience Granted First European Patent for DehydraTECH Technology

Accesswire October 21, 2020

Lexaria Bioscience Granted First European Patent for DehydraTECH(TM) Technology

TheNewsWire October 21, 2020

Lexaria Provides Update on Ongoing Business Relationship with Altria Ventures

TheNewsWire October 9, 2020

Lexaria Receives Conditional Ethics Board Approval for Pilot Human Study Using DehydraTECH Technology in Delivering Antiviral Drugs

Accesswire September 29, 2020

Lexaria Receives Conditional Ethics Board Approval for Pilot Human Study Using its DehydraTECH technology in Delivering Antiviral Drugs

TheNewsWire September 29, 2020

Lexaria Receives Orders for 4.4 Million Servings of DehydraTECH-Enabled CBD Powders

Accesswire September 23, 2020